Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

Author:

Walton Clare1ORCID,King Rachel1,Rechtman Lindsay2,Kaye Wendy2,Leray Emmanuelle3,Marrie Ruth Ann4ORCID,Robertson Neil5,La Rocca Nicholas6,Uitdehaag Bernard7,van der Mei Ingrid8,Wallin Mitchell9,Helme Anne1,Angood Napier Ceri1,Rijke Nick1,Baneke Peer1

Affiliation:

1. Multiple Sclerosis International Federation, London, UK

2. McKing Consulting Corporation, Atlanta, GA, USA

3. EA 7449 REPERES, Epidemiology, Ecole des Hautes Etudes en Sante Publique, Rennes, France

4. Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

5. Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK

6. National MS Society, West Bath, ME, USA

7. Neurology, Amsterdam UMC–Locatie VUMC, Amsterdam, Netherlands

8. Menzies Research Institute, University of Tasmania, Hobart, TAS, Australia

9. Department of Neurology, George Washington University, Washington, DC, USA

Abstract

Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. Objectives: The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. Methods: Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. Results: A total of 2.8 million people are estimated to live with MS worldwide (35.9 per 100,000 population). MS prevalence has increased in every world region since 2013 but gaps in prevalence estimates persist. The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years. Females are twice as likely to live with MS as males. Conclusions: The global prevalence of MS has risen since 2013, but good surveillance data is not universal. Action is needed by multiple stakeholders to close knowledge gaps.

Funder

Biogen

Novartis

Vanneau Trust

Associazione Italiana Sclerosi Multipla

Multiple Sclerosis Society

Merck

Bristol-Myers Squibb

Sanofi

National Multiple Sclerosis Society

Roche

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3